Vaughn Bryan T 4

What Happened

• Bryan T. Vaughn, Executive Vice President, Diagnostics at Labcorp Holdings Inc. (LH), received equity awards on February 10, 2026: a grant of 2,200 employee stock options and 730 Restricted Stock Units (RSUs).
• The reported acquisition price for both awards is $0 (these are compensation grants, not an open-market purchase). The options give the right to buy shares in the future; each RSU represents a contingent right to one share.

Key Details

• Transaction date: 2026-02-10; Form 4 filed 2026-02-12 (timely filing).
• Options: 2,200 shares (Footnote F1). Vesting: three equal annual installments beginning on the grant date (2026-02-10) (Footnote F2).
• RSUs: 730 units (Footnotes F3–F5). Vesting: three equal annual installments beginning February 10, 2027 (Footnote F4). Footnote F5 notes 730 reflects the aggregate RSUs held by the reporting person.
• Reported consideration: $0 (standard for new grant awards).
• Shares owned after transaction: not specified in the summary data provided in this request.

Context

• These are compensation awards (common for executives) rather than open-market purchases or sales. Options provide the right to buy stock later (may require exercise and payment); RSUs convert to shares when they vest.
• Because these are grants, they do not directly signal immediate buying or selling by the insider; they reflect company compensation decisions.